Complete blood count parameters as predictors of disease phenotype in pediatric inflammatory bowel disease

Ahsen Donmez Turkmen1, Gizem Tanalı2, Alican Sarısaltık3

  • 1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University Faculty of Medicine, İstanbul, Türkiye.

Insights

Complete blood count (CBC) indices can predict disease severity in pediatric ulcerative colitis and Crohn's disease. Lower absolute lymphocyte count and lymphocyte-to-monocyte ratio at diagnosis indicate more severe Crohn's disease.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Inflammatory Bowel Disease Research

Background:

  • Complete blood count (CBC) is a routine, cost-effective test.
  • Its utility in assessing pediatric inflammatory bowel disease (IBD) phenotypes and activity requires further investigation.

Purpose of the Study:

  • To determine if CBC indices can aid in assessing disease phenotype and activity at diagnosis in pediatric IBD.
  • To identify CBC parameters that predict disease behavior in Crohn's disease (CD).

Main Methods:

  • Compared CBC indices (including NLR, LMR, NMR, ALC) in 120 pediatric IBD patients (UC/CD) and 120 controls.
  • Used ROC analysis and Youden Index to find optimal cut-offs for ALC and LMR in predicting CD behavior.
  • Employed multivariate logistic regression to assess independent relationships and predict CD behavior.

Main Results:

  • IBD patients showed higher leukocyte, platelet, neutrophil, monocyte counts, and NLR than controls.
  • CD patients had significantly lower absolute lymphocyte count (ALC) than UC and control groups.
  • Decreased ALC and LMR were significant predictors of stricturing, penetrating, and perianal CD.

Conclusions:

  • CBC indices at diagnosis can assess UC severity and CD behavior in pediatric IBD.
  • These findings highlight the potential role of CBC in predicting IBD disease phenotype.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
945
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
471